Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients

Scand J Rheumatol. 2020 Nov;49(6):505-506. doi: 10.1080/03009742.2020.1800083. Epub 2020 Aug 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Antirheumatic Agents / therapeutic use
  • COVID-19*
  • Cohort Studies
  • Female
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Italy
  • Lung Diseases, Interstitial / physiopathology*
  • Lung Diseases, Interstitial / therapy
  • Male
  • Middle Aged
  • Oxygen Inhalation Therapy
  • Pulmonary Arterial Hypertension / physiopathology*
  • Pulmonary Arterial Hypertension / therapy
  • Raynaud Disease / physiopathology*
  • Retrospective Studies
  • SARS-CoV-2
  • Scleroderma, Systemic / drug therapy
  • Scleroderma, Systemic / physiopathology*
  • Telemedicine
  • Telephone
  • Ulcer / physiopathology*

Substances

  • Adrenal Cortex Hormones
  • Antirheumatic Agents
  • Hydroxychloroquine